Cold Chain Medical
Distribution
GDP-compliant temperature-controlled logistics connecting Hamburg to Amsterdam for a leading pharmaceutical distributor.
GDP-compliant temperature-controlled logistics connecting Hamburg to Amsterdam for a leading pharmaceutical distributor.
NordicPharma Distribution GmbH required a fully GDP-compliant cold chain between their Hamburg warehouse and a network of hospital pharmacies across the Netherlands and northern Belgium. Previous carrier arrangements had resulted in two temperature excursions in eighteen months — events that triggered regulatory reviews and product write-offs totalling over €400,000.
Meridax was engaged to redesign the lane from the ground up: new vehicle specification, revised dwell-time protocols at load and unload, real-time temperature data telemetry, and a contingency routing plan for both vehicle breakdown and extreme weather scenarios.
The programme launched in Q1 2023 and operates five days per week. Since go-live, it has completed over 840 deliveries with zero temperature excursions and a 99.6% on-time rate against the agreed delivery windows.
"Temperature integrity is non-negotiable. A single excursion can void an entire consignment — and cost us more in regulatory fallout than the freight itself."
Head of Supply Chain, NordicPharma Distribution GmbH
NordicPharma's existing arrangement used a general freight carrier that had retrofitted temperature monitoring onto standard refrigerated trailers. The system lacked pre-conditioning protocols, had no redundancy on temperature logging, and offered no live visibility between departure and delivery confirmation.
Hospital pharmacy clients operate on strict receipt windows. Any delivery arriving outside its window — even by 30 minutes — triggers a formal deviation report under Dutch and Belgian medicines regulation. Three deviations in a rolling 12-month period can result in a temporary licence suspension for the distributor.
The brief to Meridax was unambiguous: eliminate excursion risk entirely, provide continuous temperature data, and achieve a 99%+ on-time rate against contractual windows. There was no tolerance for a transition period.
Four interlocking changes — each one addressing a specific failure mode from the previous arrangement.
We replaced the general carrier's retrofitted fleet with purpose-built ATP-certified refrigerated HGVs maintained at 2–8°C for pharmaceutical loads. Every vehicle undergoes a four-hour pre-conditioning cycle before loading — confirmed by a calibrated HACCP data logger installed in the load zone. Trailers carry dual cooling units with automatic failover, so a primary unit fault does not trigger a temperature event.
Each vehicle transmits continuous temperature and location data through our TempTrace platform. NordicPharma's quality assurance team has direct read access — they see the same live feed as our operations centre. Automated alerts fire within 90 seconds if temperature deviation exceeds 0.5°C of threshold. Every delivery generates a tamper-evident temperature report in the format required by Dutch and Belgian medicines authorities.
Temperature excursions in the prior arrangement most often occurred during loading at the Hamburg warehouse and unloading at hospital dock bays — not in transit. We redesigned both procedures: cargo transfer at Hamburg now happens through a dock-to-vehicle sealed transfer channel, reducing open-air exposure from an average of 22 minutes to under 4. At receiving pharmacies, Meridax drivers are trained in controlled unload sequences and carry portable thermal shrouds for any unscheduled waiting periods.
A dedicated breakdown response SLA was established: a replacement refrigerated vehicle with pre-conditioned load space arrives within 90 minutes at any point along the Hamburg–Amsterdam corridor. Contingency routes bypassing known bottleneck zones were modelled for peak-season and storm-weather conditions, and drivers are briefed on these alternatives at each departure. The result is that no breakdown or road closure has yet required a delivery window miss since the programme launched.
Measured across 840+ deliveries over 18 months of live operation on the Hamburg–Amsterdam cold chain programme.
Zero temperature excursions recorded across all shipments since programme go-live in Q1 2023.
Against contractual pharmacy delivery windows — compared to 91.4% under the prior carrier arrangement.
Versus previous arrangement when accounting for eliminated write-offs, regulatory costs, and carrier deviation penalties.
"Eighteen months with Meridax and not a single temperature event. That track record has removed cold chain performance as a risk item in our board-level supply chain reviews — which we never thought possible with a third-party carrier."
Director of Quality Assurance, NordicPharma Distribution GmbH